Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction

Autor: Marie-Claude Drolet, J. Luis Guerrero, Patrick Mathieu, Marie-Annick Clavel, Jonathan Beaudoin, Claudia Côté-Laroche, Ons Marsit, Marie Arsenault, Marie-Chloé Boulanger, Dae-Hee Kim, Robert A. Levine, Philipp E. Bartko, Elena Aikawa, Joyce Bischoff, Mark D. Handschumacher, Sandra Hadjadj, Marc-André Bouchard, Jacques Couet, Marine Clisson, Philippe Pibarot
Rok vydání: 2019
Předmět:
Male
medicine.medical_specialty
Population
Aortic Valve Insufficiency
Echocardiography
Three-Dimensional

Myocardial Infarction
Myocardial Ischemia
Infarction
Regurgitation (circulation)
030204 cardiovascular system & hematology
03 medical and health sciences
0302 clinical medicine
Mitral valve
Internal medicine
medicine
Animals
cardiovascular diseases
030212 general & internal medicine
Myocardial infarction
education
Mitral regurgitation
education.field_of_study
Ischemic cardiomyopathy
Sheep
Ventricular Remodeling
business.industry
Mitral Valve Insufficiency
medicine.disease
Fibrosis
Magnetic Resonance Imaging
Extracellular Matrix
medicine.anatomical_structure
Regurgitant fraction
cardiovascular system
Cardiology
Mitral Valve
Female
Tricuspid Valve
Cardiology and Cardiovascular Medicine
business
Tomography
X-Ray Computed
Zdroj: Journal of the American College of Cardiology. 75(4)
ISSN: 1558-3597
Popis: Background Mitral leaflet enlargement has been identified as an adaptive mechanism to prevent mitral regurgitation in dilated left ventricles (LVs) caused by chronic aortic regurgitation (AR). This enlargement is deficient in patients with functional mitral regurgitation, which remains frequent in the population with ischemic cardiomyopathy. Maladaptive fibrotic changes have been identified in post-myocardial infarction (MI) mitral valves. It is unknown if these changes can interfere with valve growth and whether they are present in other valves. Objectives This study sought to test the hypothesis that MI impairs leaflet growth, seen in AR, and induces fibrotic changes in mitral and tricuspid valves. Methods Sheep models of AR, AR + MI, and controls were followed for 90 days. Cardiac magnetic resonance, echocardiography, and computed tomography were performed at baseline and 90 days to assess LV volume, LV function, mitral regurgitation and mitral leaflet size. Histopathology and molecular analyses were performed in excised valves. Results Both experimental groups developed similar LV dilatation and dysfunction. At 90 days, mitral valve leaflet size was smaller in the AR + MI group (12.8 ± 1.3 cm2 vs. 15.1 ± 1.6 cm2, p = 0.03). Mitral regurgitant fraction was 4% ± 7% in the AR group versus 19% ± 10% in the AR + MI group (p = 0.02). AR + MI leaflets were thicker compared with AR and control valves. Increased expression of extracellular matrix remodeling genes was found in both the mitral and tricuspid leaflets in the AR + MI group. Conclusions In these animal models of AR, the presence of MI was associated with impaired adaptive valve growth and more functional mitral regurgitation, despite similar LV size and function. More pronounced extracellular remodeling was observed in mitral and tricuspid leaflets, suggesting systemic valvular remodeling after MI.
Databáze: OpenAIRE